Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01457521 · ClinicalTrials.gov registry record · Phase 4

Pain Control In First Trimester Medical Abortion: A Randomized Trial

A Phase 4 study of Pain, sponsored by Gynuity Health Projects.

Completed
Registry status
Phase 4
Development phase
250
Enrollment target
2
Study locations

NCT01457521 is a Phase 4 study of Pain that has completed, run by Gynuity Health Projects. The registered enrollment target is 250 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01457521, a Phase 4 study of Pain, has completed, sponsored by Gynuity Health Projects.

COMPLETED
Registry status
Phase 4
Development phase
250 participants
Enrollment target
2
Study locations

Study Summary

This trial will compare two oral analgesic regimens in women undergoing first trimester medical abortion with mifepristone and misoprostol. The primary study outcome is pain.

Conditions Studied

Pain

Interventions

  • DRUG Ibuprofen

Study Locations (2)

Illinois

  • Family Planning Associates Medical Group - Chicago

New York

  • Planned Parenthood of New York City, Inc. - New York

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2011-10
Est. Completion 2012-12
Phase Phase 4

Sponsor

Gynuity Health Projects

29 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01457521

The ClinicalTrials.gov registry entry for NCT01457521 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower). The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Ibuprofen is the first listed.

NCT01457521 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, New York.

Frequently Asked Questions

What is clinical trial NCT01457521 about?

NCT01457521 is a clinical study titled "Pain Control In First Trimester Medical Abortion: A Randomized Trial". This trial will compare two oral analgesic regimens in women undergoing first trimester medical abortion with mifepristone and misoprostol. The primary study outcome is pain.

What is the current status of trial NCT01457521?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2011-10. Estimated completion is 2012-12.

What conditions does trial NCT01457521 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT01457521?

The interventions under investigation include: Ibuprofen (DRUG).

Who is sponsoring clinical trial NCT01457521?

This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01457521 being conducted?

This trial has 2 study locations across Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.